Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis

Published:2023-05-27 Issue:9 Volume:44 Page:2999-3003
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Zheng Qian,Cheng Yongran,Song Chengxin,Feng Zhanhui^ORCID,Xu Zucai

Funder

National Natural Science Foundation of China

Science and Technology Fund of Guizhou Health Commission

Cultivation project of National Natural Science Foundation of China

the cultivate project 2021 for National Natural Science Foundation of China, Affiliated Hospital of Guizhou Medical University

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-023-06875-w.pdf

Reference14 articles.

1. Trinchillo A, Esposito M, Habetswallner F, Tuccillo F, De Martino BM (2023) COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation. Neurol Sci 44(2):447–450. https://doi.org/10.1007/s10072-022-06584-w

2. Doron A, Piura Y, Vigiser I, Kolb H, Regev K, Nesher N, Karni A (2022) BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves. J Neurol 269(12):6193–6201. https://doi.org/10.1007/s00415-022-11303-8

3. Farina A, Falso S, Cornacchini S, Spagni G, Monte G, Mariottini A, Massacesi L, Barilaro A, Evoli A, Damato V (2022) Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: a multicenter experience. Eur J Neurol 29(8):2505–2510. https://doi.org/10.1111/ene.15348

4. Gamez J, Gamez A, Carmona F (2022) Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis. Muscle Nerve 6(5):612–617. https://doi.org/10.1002/mus.27703

5. Ishizuchi K, Takizawa T, Sekiguchi K, Motegi H, Oyama M, Nakahara J, Suzuki S (2022) Flare of myasthenia gravis induced by COVID-19 vaccines. J Neurol Sci 436:120225. https://doi.org/10.1016/j.jns.2022.120225

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3